TY - JOUR
T1 - Antimicrobial activity of ruthenium-based intercalators
AU - Bolhuis, Albert
AU - Hand, Lorna
AU - Marshall, Julia E.
AU - Richards, Adair D.
AU - Rodger, Alison
AU - Aldrich-Wright, Janice
PY - 2011
Y1 - 2011
N2 - Multidrug resistance of bacterial pathogens is a major problem and there is a clear need for the development of new types of antibiotics. Here we investigated the antimicrobial activity of ruthenium(II) based DNA-intercalating complexes. These complexes were found to have no activity in vitro against the Gram-negative bacterium Escherichia coli, but the complexes were clearly active against the Gram-positive bacteria Bacillus subtilis and Staphylococcus aureus. In vivo activity has also been demonstrated for one of the compounds using a simple infection model, the nematode Caenorhabditis elegans. Importantly, this also showed that the compound tested was not toxic to the nematodes.
AB - Multidrug resistance of bacterial pathogens is a major problem and there is a clear need for the development of new types of antibiotics. Here we investigated the antimicrobial activity of ruthenium(II) based DNA-intercalating complexes. These complexes were found to have no activity in vitro against the Gram-negative bacterium Escherichia coli, but the complexes were clearly active against the Gram-positive bacteria Bacillus subtilis and Staphylococcus aureus. In vivo activity has also been demonstrated for one of the compounds using a simple infection model, the nematode Caenorhabditis elegans. Importantly, this also showed that the compound tested was not toxic to the nematodes.
UR - http://handle.uws.edu.au:8081/1959.7/536635
U2 - 10.1016/j.ejps.2010.12.004
DO - 10.1016/j.ejps.2010.12.004
M3 - Article
SN - 0928-0987
VL - 42
SP - 313
EP - 317
JO - European Journal of Pharmaceutical Sciences
JF - European Journal of Pharmaceutical Sciences
IS - 4
ER -